LHCGR rs10734410: Reproductive Genetics and PCOS Risk
The rs10734410 single nucleotide polymorphism is an intronic DNA variant located within the LHCGR gene on chromosome 2. This locus encodes the luteinizing hormone/choriogonadotropin receptor, which plays an essential role in gonadal function, steroidogenesis, and ovulation. Preliminary research has evaluated rs10734410 as a candidate marker for polycystic ovary syndrome (PCOS) susceptibility, though evidence remains limited.
What each genotype means
Typical risk profile
You carry two copies of the major A allele for this variant in the LHCGR gene. Research indicates that this genotype is not associated with elevated genetic susceptibility to polycystic ovary syndrome (PCOS). However, PCOS is a multifactorial condition influenced by many lifestyle and genetic factors, so overall risk is determined by multiple influences.
Carried by approximately 50% to 55% of individuals across European and East Asian ancestral populations.
Slightly increased risk profile
You carry one copy of the G risk allele and one copy of the A reference allele. Population studies have identified a modest statistical association between carrying the G allele and polycystic ovary syndrome (PCOS) susceptibility, though evidence remains limited and varies between ancestral groups. Having this genotype does not cause or diagnose PCOS.
Carried by roughly 35% to 40% of individuals in East Asian and European cohorts.
Elevated risk profile
You carry two copies of the minor G risk allele for this LHCGR variant. Some genome-wide and candidate gene studies have noted a higher statistical odds of polycystic ovary syndrome (PCOS) among homozygous carriers compared to non-carriers, though findings are limited and not fully consistent across all populations. This is a statistical correlation rather than a diagnosis, and many individuals with this genotype never develop PCOS.
Found in approximately 5% to 8% of individuals of European and East Asian ancestry.
What Is the rs10734410 Polymorphism?
The rs10734410 variant is a single nucleotide polymorphism (SNP) situated within the human luteinizing hormone/choriogonadotropin receptor (LHCGR) gene locus on chromosome 2p16.3. As cataloged in reference resources such as dbSNP and Ensembl, the variant represents a single base-pair change, alternating between the common A allele and the minor G allele. Because this SNP resides in a non-coding intronic region of the gene, it does not alter the primary amino acid sequence of the resulting protein. Instead, scientists investigate variants like rs10734410 to explore whether they influence gene regulatory processes, such as alternative splicing, transcription factor binding affinity, or regional chromatin accessibility. Alternatively, this SNP may serve as a neutral genetic tag that is inherited together with other functional mutations nearby via linkage disequilibrium.
The Biological Role of the LHCGR Gene
The LHCGR gene provides instructions for producing a critical G-protein coupled receptor that responds to two major hormones: luteinizing hormone (LH) and human chorionic gonadotropin (hCG). According to MedlinePlus Genetics, the receptor is expressed primarily within the gonads, where it directs reproductive development and hormonal signaling. In the ovaries, LH binding triggers follicle maturation, induces ovulation, and stimulates the corpus luteum to produce progesterone. It also promotes the synthesis of androgens, which are subsequent building blocks for estradiol production. In males, the receptor is essential for stimulating testicular Leydig cells to produce testosterone both during fetal sex differentiation and adult life. Because LHCGR sits at the heart of the hypothalamic-pituitary-gonadal axis, any genetic alterations that subtly modulate its expression or sensitivity could influence downstream reproductive and metabolic balance.
Research Associations and PCOS Susceptibility
Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine condition characterized by hyperandrogenism, ovulatory dysfunction, and metabolic changes. Early genome-wide association studies (GWAS) pinpointed the LHCGR locus as a primary susceptibility region for PCOS, sparking interest in specific candidate variants across diverse populations. Observational studies and meta-analyses have evaluated multiple polymorphisms within LHCGR, including rs10734410, to determine whether carrying specific alleles correlates with altered risk for developing PCOS. Currently, the evidence connecting rs10734410 specifically to PCOS risk is classified as limited. While some cohorts have identified modest statistical correlations with ovulatory traits or hormone ratios, other populations show null findings. As highlighted in reproductive genetics reviews, associations at this locus frequently demonstrate significant ethnic heterogeneity, meaning effects observed in East Asian cohorts may not replicate cleanly in European or other ancestral backgrounds.
Population Frequency and Ancestral Distribution
Allele frequencies for rs10734410 show notable variation among global groups recorded in population databases like gnomAD and 1000 Genomes. The minor allele displays a frequency of approximately 0.26 across cohorts of European and East Asian descent, indicating that roughly a quarter of chromosomes in these groups carry the alternative base. Consequently, heterozygous individuals are common in these groups, whereas homozygous carriers of the minor allele represent a smaller fraction of the population. In other geographic ancestries, such as African and Admixed American populations, frequency estimates can fluctuate. Because PCOS is a multifactorial condition influenced by hundreds of genetic loci alongside environmental factors, the presence or absence of a relatively common variant like rs10734410 alone does not dictate clinical outcomes across different ancestral groups.
Interpreting Your Genetic Results Responsibly
Discovering your rs10734410 genotype provides personal insight into your unique biological blueprint, but it is essential to understand what this information cannot do. This variant is not diagnostic; having an associated risk allele does not mean you have PCOS or will inevitably develop ovulatory issues, nor does an absence of the variant protect you from reproductive conditions. PCOS is diagnosed through established clinical criteria, such as the Rotterdam Consensus, involving physical examinations, pelvic imaging, and laboratory hormone evaluations. Direct-to-consumer genetic findings should never be used to initiate self-treatment or adjust prescription medications. If you have concerns about irregular cycles, fertility, or signs of elevated androgens, consider bringing your results to an endocrinologist, gynecologist, or genetic counselor for comprehensive medical evaluation.
How common is this variant?
The rs10734410 minor allele exhibits a frequency of approximately 0.26 in East Asian and European cohorts, while varying across other global ancestral groups.
Frequently asked questions
Can rs10734410 determine if I will develop polycystic ovary syndrome?
No, rs10734410 cannot determine whether you will develop PCOS. PCOS is a complex, multifactorial disorder caused by interactions among dozens of genetic variants and environmental factors. Having a particular genotype at rs10734410 only reflects a minor statistical association observed in research settings, not a definitive diagnosis.
How does the LHCGR gene affect female reproduction?
The LHCGR gene encodes a cellular receptor that responds to luteinizing hormone and human chorionic gonadotropin. In the ovaries, this receptor is vital for follicle maturation, triggering ovulation, and stimulating hormone production such as progesterone and androgens. Disruptions or natural variations in its regulation can alter hormonal signaling pathways.
Does this genetic variant affect fertility treatments or IVF response?
While the LHCGR receptor is central to how ovaries respond to hormonal stimulation during fertility treatments, evidence directly tying rs10734410 to in vitro fertilization (IVF) outcomes is limited. Patients undergoing assisted reproductive technology should always discuss their medication protocols and ovarian response profiles with their reproductive endocrinologist.
What should I do if my raw genetic data shows a PCOS-linked genotype?
You should treat consumer genetic results as educational and discuss any personal health questions with a medical provider. If you experience symptoms such as irregular menstrual periods, excessive hair growth, severe acne, or difficulty conceiving, a physician can perform standard hormonal and ultrasound evaluations to provide an accurate diagnosis.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10734410?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LHCGR
Intronic regulatory variant in LHCGR modulating luteinizing hormone and human chorionic gonadotropin signaling sensitivity during human folliculogenesis.
Polymorphism in the luteinizing hormone/choriogonadotropin receptor gene linked to variation in ovarian sensitivity to gonadotropins during assisted reproduction.
A missense polymorphism (N291S) in the luteinizing hormone/choriogonadotropin receptor gene that influences receptor signaling efficiency and sensitivity to exogenous gonadotropins in ovarian stimulation protocols.
Regulatory SNP in LHCGR associated with ovarian responsiveness.
Intronic regulatory variant in LHCGR modulating luteinizing hormone and human chorionic gonadotropin signaling, linked to susceptibility to polycystic ovary syndrome (PCOS).
Activating missense mutation in LHCGR causing familial male-limited precocious puberty (testotoxicosis).